Free Access
| Issue |
Med Sci (Paris)
Volume 30, Number 5, Mai 2014
|
|
|---|---|---|
| Page(s) | 576 - 583 | |
| Section | Forum | |
| DOI | https://doi.org/10.1051/medsci/20143005022 | |
| Published online | 13 June 2014 | |
- Regulation (EC) No 1394/2007 of the European parliament and of the Council of 13 November 2007 on Advanced therapy medicinal products and amending. Directive 2001/83/EC and regulation (EC) No 726/2004. [Google Scholar]
- Blanquet M, de Grove-Valdeyron N. Les enjeux et les apports du règlement communautaire concernant les médicaments de thérapie innovante. Revue Affaires Européennes 2008 ; 2008/4 : 689–721. [Google Scholar]
- Ancans J. Cell therapy medicinal product regulatory framework in Europe, its application for MSC-based therapy development. Front Immunol 2012 ; 3 : 253. [CrossRef] [PubMed] [Google Scholar]
- Taboulet F. Les médicaments de thérapie innovante : quelles spécificités en droit pharmaceutique ? In: Mahalatchimy A, Rial-Sebbag E, coords, L’humain médicament. Paris : Quaderni n°81, Éditions de la Maison des sciences de l’homme, Printemps 2013 : 15–27. [Google Scholar]
- Lucas-Samuel S. Thérapie innovante : du cadre réglementaire européen au cadre réglementaire national. Transfus Clin Biol 2013 ; 20 : 221–224. [CrossRef] [PubMed] [Google Scholar]
- Pearce KF, Hildebrandt M, Greinix H, et al. Regulation of advanced therapy medicinal products in Europe and the role of academia. Cytotherapy 2014 ; 16 : 289–297. [CrossRef] [PubMed] [Google Scholar]
- Sipp D, Turner L. Stem cells. U.S. regulation of stem cells as medical products. Science 2012 ; 338 : 1296–1297. [CrossRef] [PubMed] [Google Scholar]
- Bryant LM, Christopher DM, Giles AR, et al. Lessons learned from the clinical development and market authorization of Glybera. Hum Gene Ther Clin Dev 2013 ; 24 : 55–64. [CrossRef] [PubMed] [Google Scholar]
- Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. New Engl J Med 2010 ; 363 : 411–422. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.